NEW YORK — Japanese diagnostics firm Sysmex said on Wednesday that it has received Class III approval from China’s National Medical Products Administration for its Lynoamp BC in vitro diagnostic reagent.
NEW YORK — Japanese diagnostics firm Sysmex said on Wednesday that it has received Class III approval from China’s National Medical Products Administration for its Lynoamp BC in vitro diagnostic reagent.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.